These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 26245496

  • 1. Validation of the Chinese version of EORTC QLQ-BM22 in patients with bone metastases.
    Zhang L, Su YJ, Chen JY, Liao ZC, Luo ZQ, Xie SM, Zhang J, Lin YS, Guo H, Sun WL, Pekbay B, Miller AR, Luo L, Rui YH, Li MH, Wang CL.
    Support Care Cancer; 2016 Mar; 24(3):1019-24. PubMed ID: 26245496
    [Abstract] [Full Text] [Related]

  • 2. A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10).
    Marschner N, Wilke J, Reschke D, Kaiser F, Schmoor C, Grugel R, Boller E.
    J Med Econ; 2018 Sep; 21(9):920-929. PubMed ID: 29874105
    [Abstract] [Full Text] [Related]

  • 3. Validation of the Polish version of the EORTC QLQ-BM22 module for the assessment of health-related quality of life in patients with bone metastases.
    Püsküllüoğlu M, Tomaszewski KA, Bottomley A, Holden L, Tomaszewska IM, Głowacki R, Bereza K, Golec EB, Chow E, Krzemieniecki K.
    Qual Life Res; 2014 Mar; 23(2):527-32. PubMed ID: 23912854
    [Abstract] [Full Text] [Related]

  • 4. A prospective study validating the EORTC QLQ-BM22 bone metastases module in patients with painful bone metastases undergoing palliative radiotherapy.
    Raman S, Ding K, Chow E, Meyer RM, Nabid A, Chabot P, Coulombe G, Ahmed S, Kuk J, Dar AR, Mahmud A, Fairchild A, Wilson CF, Wu JS, Dennis K, DeAngelis C, Wong RK, Zhu L, Brundage M.
    Radiother Oncol; 2016 May; 119(2):208-12. PubMed ID: 27157890
    [Abstract] [Full Text] [Related]

  • 5. International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases.
    Chow E, Nguyen J, Zhang L, Tseng LM, Hou MF, Fairchild A, Vassiliou V, Jesus-Garcia R, Alm El-Din MA, Kumar A, Forges F, Chie WC, Bottomley A, European Organization for Research Treatment of Cancer Quality of Life Group.
    Cancer; 2012 Mar 01; 118(5):1457-65. PubMed ID: 21837676
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the EORTC QLQ-BM22 and the BOMET-QOL quality of life questionnaires in patients with bone metastases.
    Bedard G, Zeng L, Poon M, Lam H, Lauzon N, Chow E.
    Asia Pac J Clin Oncol; 2014 Jun 01; 10(2):118-23. PubMed ID: 23551978
    [Abstract] [Full Text] [Related]

  • 7. Validation of EORTC QLQ-OES18 for Chinese patients with esophageal cancer.
    Dai Z, Lang W, Yang H, Tian J, Sun W, Pekbay B, Lin Y, Wang M, Cui B, Yang S, Li H, Luo L, Guo H, Zhang L.
    Dis Esophagus; 2017 Oct 01; 30(10):1-7. PubMed ID: 28859386
    [Abstract] [Full Text] [Related]

  • 8. The reliability and validity of the Iranian version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with Bone Metastases: the EORTC QLQ-BM22.
    Yekaninejad MS, Ahmadzadeh A, Mosavi SH, Saffari M, Pakpour AH, Tolooei F, Chow E, Bottomley A.
    Expert Rev Pharmacoecon Outcomes Res; 2014 Feb 01; 14(1):147-56. PubMed ID: 24328844
    [Abstract] [Full Text] [Related]

  • 9. [The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire for Japanese patients with bone metastases--The Japanese version of the EORTC QLQ-BM22].
    Satoh T, Kobayashi K, Hori T, Iida S, Sato A, Ishiguro H, Chow E, Shimozuma K.
    Gan To Kagaku Ryoho; 2010 Aug 01; 37(8):1507-12. PubMed ID: 20716876
    [Abstract] [Full Text] [Related]

  • 10. Validation of the chinese version of the EORTC QLQ-CR29 in patients with colorectal cancer.
    Lin JB, Zhang L, Wu DW, Xi ZH, Wang XJ, Lin YS, Fujiwara W, Tian JR, Wang M, Peng P, Guo A, Yang Z, Luo L, Jiang LY, Li QQ, Zhang XY, Zhang YF, Xu HW, Yang B, Li XL, Lei YX.
    World J Gastroenterol; 2017 Mar 14; 23(10):1891-1898. PubMed ID: 28348496
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases.
    Zeng L, Chow E, Zhang L, Tseng LM, Hou MF, Fairchild A, Vassiliou V, Jesus-Garcia R, Alm El-Din MA, Kumar A, Forges F, Chie WC, Bedard G, Bottomley A.
    Support Care Cancer; 2012 Dec 14; 20(12):3307-13. PubMed ID: 22562607
    [Abstract] [Full Text] [Related]

  • 13. Questionnaire to assess quality of life in patients with breast cancer - Validation of the Chinese version of the EORTC QLQ-BR 53.
    Zhang Z, Zhang X, Wei L, Lin Y, Wu D, Xie S, Yue L, Tian J, Zhang Y, Song Q, Woo SM, Miller AR, Luo L, Zhang L.
    Breast; 2017 Apr 14; 32():87-92. PubMed ID: 28068605
    [Abstract] [Full Text] [Related]

  • 14. Reliability and validity of the Amharic version of European Organization for Research and Treatment of cervical Cancer module for the assessment of health related quality of life in women with cervical cancer in Addis Ababa, Ethiopia.
    Araya LT, Gebretekle GB, Gebremariam GT, Fenta TG.
    Health Qual Life Outcomes; 2019 Jan 14; 17(1):13. PubMed ID: 30642359
    [Abstract] [Full Text] [Related]

  • 15. Psychometric Validation of the Malaysian Chinese Version of the EORTC QLQ-C30 in Colorectal Cancer Patients.
    Magaji BA, Moy FM, Roslani AC, Law CW, Sagap I.
    Asian Pac J Cancer Prev; 2015 Jan 14; 16(18):8107-12. PubMed ID: 26745046
    [Abstract] [Full Text] [Related]

  • 16. Quality of life in responders after palliative radiation therapy for painful bone metastases using EORTC QLQ-C30 and EORTC QLQ-BM22: results of a Brazilian cohort.
    Mendez LC, Raman S, Wan BA, da Silva JLP, Moraes FY, Lima KMLB, Silva MF, Diz MDPE, Chow E, Marta GN.
    Ann Palliat Med; 2017 Aug 14; 6(Suppl 1):S65-S70. PubMed ID: 28595442
    [Abstract] [Full Text] [Related]

  • 17. Validation of EORTC QLQ-LC43 for Chinese patients with lung cancer.
    Zhang L, Su Y, Hua Y, Liu W, Yue L, Wu J, Luo L, Lü W, Mu-Lian Woo S, Miller AR, Xie S, Zhu H, Pang C, Zhang J, Wang C.
    Lung Cancer; 2014 Jul 14; 85(1):94-8. PubMed ID: 24831272
    [Abstract] [Full Text] [Related]

  • 18. Translation into Portuguese, cross-cultural adaptation and validation of "The European Organization for Research and Treatment of Cancer-Quality of Life Questionnaire-Bone Metastases-22".
    Miki-Rosário N, Garcia Filho RJ, Garcia JG, Dini GM, Bottomley A, Chow E, Sabino Neto M.
    Ann Palliat Med; 2016 Jul 14; 5(3):190-5. PubMed ID: 27334351
    [Abstract] [Full Text] [Related]

  • 19. Minimal clinically important differences in the EORTC QLQ-BM22 and EORTC QLQ-C15-PAL modules in patients with bone metastases undergoing palliative radiotherapy.
    Raman S, Ding K, Chow E, Meyer RM, Nabid A, Chabot P, Coulombe G, Ahmed S, Kuk J, Dar AR, Mahmud A, Fairchild A, Wilson CF, Wu JSY, Dennis K, DeAngelis C, Wong RKS, Zhu L, Brundage M.
    Qual Life Res; 2016 Oct 14; 25(10):2535-2541. PubMed ID: 27138964
    [Abstract] [Full Text] [Related]

  • 20. Psychometric properties of the EORTC QLQ-C30 in Uganda.
    Naamala A, Eriksson LE, Orem J, Nalwadda GK, Kabir ZN, Wettergren L.
    Health Qual Life Outcomes; 2021 Apr 23; 19(1):131. PubMed ID: 33892718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.